Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 157-168 of 1871 results.
"Findings from this review suggest that non-pharmacological interventions may serve as effective, safe, and feasible adjuncts for pain management during peripheral venous cannulation" Romańczuk et al (2026).
"This article provides a review of the critical role of the nurse in identifying risks and applying best practices in NC care, including disinfection, clamping, flushing, and timely replacement" Moureau and Gorski (2026).
"To evaluate whether, in children treated in paediatric intensive care units (PICU) with peripheral venous access devices (PVADs) receiving intermediate- or high-risk peripheral intravenous medications, the use of a tissue-infiltration biosensor (ivWatch), compared to standard care, reduces extravasation injuries" McBride et al (2026).
"In both adult and pediatric cohorts, patients with PIVC-associated complications had significantly higher total hospitalization cost, LOS, and 30-day readmission risks than those without complications" Moon et al (2026).
"Prolonged catheter use and femoral insertion are major modifiable risk factors for CABSI in hemodialysis patients. With Gram-negative pathogens like Pseudomonas aeruginosa and MRSA predominantly responsible, targeted empirical antimicrobial strategies and early arteriovenous fistula creation are crucial to mitigate infection risks in resource-limited settings" Faheem et al (2026).
"In this study, one-third of PIVCs were non-indicated and were mainly associated with low-acuity clinical presentations and organisational factors. These findings highlight substantial opportunities to improve the appropriateness of PIVC use in emergency care" Drugeon et al (2026).
New publication on Totally implanted vascular access devices-related infections in oncology and hematology: A retrospective single-center study from the Journal of Vascular Access Totally implanted…
"Our findings suggest that MCs increased CRVT risk and reduced the CRBSIs risk relative to PICCs. These findings can help guide future analyses and direct comparative RCTs to further characterize the efficacy and risks of PICCs vs midline catheters" Tian et al (2026).
"PIVO significantly reduced blood culture contamination and demonstrated strong feasibility in a high-acuity emergency department" Skuras and Curylo (2026).
"Ultrasound has increasing use and utility in neonatal central venous access, there lacks consensus on methods of use and measured outcomes with minimal current focus on the most common venous access catheters" Hall et al (2026).
"Y-site administration of 16 binary admixtures identified as incompatible is not recommended. The preparatory study results are suitable to complete incompatibility-reducing infusion schemes. Clinical pharmacists should implement incompatibility-reducing tools in intensive care patients" Kreysing et al (2026).
"A pragmatic two-tier pathway – POCUS and/or IC-ECG as first-line confirmation, with selective CXR for unresolved uncertainty or high-risk scenarios – may balance efficiency with governance and medico-legal requirements" Orso et al (2026).
